The efficacy of the cyclin-dependent kinase 4/6 inhibitor in endometrial cancer

MLA

Keisuke Ashihara, et al. “The Efficacy of the Cyclin-Dependent Kinase 4/6 Inhibitor in Endometrial Cancer.” PLoS ONE, vol. 12, no. 5, Jan. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1600a437519e7c27160fec8cd0e66cd3&authtype=sso&custid=ns315887.

APA

Keisuke Ashihara, Hiroshi Sasaki, Yoshimichi Tanaka, Satoshi Tsunetoh, Yoshito Terai, Masahide Ohmichi, Satoe Fujiwara, & Tomohito Tanaka. (2017). The efficacy of the cyclin-dependent kinase 4/6 inhibitor in endometrial cancer. PLoS ONE, 12(5).

Chicago

Keisuke Ashihara, Hiroshi Sasaki, Yoshimichi Tanaka, Satoshi Tsunetoh, Yoshito Terai, Masahide Ohmichi, Satoe Fujiwara, and Tomohito Tanaka. 2017. “The Efficacy of the Cyclin-Dependent Kinase 4/6 Inhibitor in Endometrial Cancer.” PLoS ONE 12 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1600a437519e7c27160fec8cd0e66cd3&authtype=sso&custid=ns315887.